Literature DB >> 7926008

The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.

D S Choi1, G Birraux, J M Launay, L Maroteaux.   

Abstract

The human serotonin 5-HT2B receptor, isolated from a human liver cDNA library, was transfected in COS-1 cells. Its pharmacological profile shows divergence with serotonin 5-HT2B receptors of other species. In particular, although strong correlation is observed between the human and the rat 5-HT2B receptor pharmacology, the correlation is almost as significant for the mouse 5-HT2B and the human 5-HT1D receptor agonists. The major sites of expression of its mRNA are in the human liver and kidney, with detectable expression in lung and heart. Therefore, this human 5-HT2B receptor could account for functions attributed to the peripheral 5-HT1D/5-HT2-like receptors, especially in the cardiovascular system. Thus, its detailed original pharmacology is of prime importance for therapeutic drug development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926008     DOI: 10.1016/0014-5793(94)00968-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.

Authors:  J P Brouland; P Manivet; I Brocheriou-Spelle; M Wassef; M F Le Bodic; A Lavergne; J M Launay
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia.

Authors:  J Erdmann; D Shimron-Abarbanell; M Rietschel; M Albus; W Maier; J Körner; B Bondy; K Chen; J C Shih; M Knapp; P Propping; M M Nöthen
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

Review 3.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

4.  Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.

Authors:  E Glusa; A Roos
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.

Authors:  B Schaerlinger; P Hickel; N Etienne; L Guesnier; L Maroteaux
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

Review 6.  Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease.

Authors:  Terry-Elinor Reid; Krishna Kumar; Xiang Simon Wang
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

7.  The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.

Authors:  D W Bonhaus; C Bach; A DeSouza; F H Salazar; B D Matsuoka; P Zuppan; H W Chan; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Positive regulation of raphe serotonin neurons by serotonin 2B receptors.

Authors:  Arnauld Belmer; Emily Quentin; Silvina L Diaz; Bruno P Guiard; Sebastian P Fernandez; Stéphane Doly; Sophie M Banas; Pothitos M Pitychoutis; Imane Moutkine; Aude Muzerelle; Anna Tchenio; Anne Roumier; Manuel Mameli; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.